只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-05-15 2026-05-19 | TVTX Travere Therapeutics, Inc. | Coughlin Timothy Director | 卖出（S） | 3,250 | US$43.49 | US$141,342.50 | 52,250 | SEC |
| 2026-05-06 2026-05-06 | TVTX Travere Therapeutics, Inc. | REED ELIZABETH E Officer · Chief Legal Officer and GC | 卖出（S） | 2,076 | US$43.95 | US$91,240.20 | 105,211 | SEC |
| 2026-05-06 2026-05-06 | TVTX Travere Therapeutics, Inc. | ROTE WILLIAM E. Officer · Chief Research Officer | 卖出（S） | 2,763 | US$43.95 | US$121,433.85 | 115,474 | SEC |
| 2026-05-06 2026-05-06 | TVTX Travere Therapeutics, Inc. | Dube Eric M Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 22,500 | US$43.95 | US$988,875.00 | 432,886 | SEC |
| 2026-05-06 2026-05-06 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 311 | US$43.95 | US$13,668.45 | 113,238 | SEC |
| 2026-05-06 2026-05-06 | TVTX Travere Therapeutics, Inc. | Cline Christopher R. Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 310 | US$43.95 | US$13,624.50 | 118,658 | SEC |
| 2026-05-05 2026-05-06 | TVTX Travere Therapeutics, Inc. | REED ELIZABETH E Officer · Chief Legal Officer and GC | 卖出（S） | 2,174 | US$46.65 | US$101,417.10 | 107,287 | SEC |
| 2026-05-05 2026-05-06 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. Director | 卖出（S） | 4,500 | US$46.65 | US$209,925.00 | 37,500 | SEC |
| 2026-05-05 2026-05-06 | TVTX Travere Therapeutics, Inc. | Heerma Peter Officer · CHIEF COMMERCIAL OFFICER | 卖出（S） | 2,174 | US$46.65 | US$101,417.10 | 140,684 | SEC |
| 2026-05-05 2026-05-06 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 2,174 | US$46.65 | US$101,417.10 | 113,549 | SEC |
| 2026-05-05 2026-05-06 | TVTX Travere Therapeutics, Inc. | Cline Christopher R. Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 2,181 | US$46.65 | US$101,743.65 | 118,968 | SEC |
| 2026-05-04 2026-05-06 | TVTX Travere Therapeutics, Inc. | REED ELIZABETH E Officer · Chief Legal Officer and GC | 卖出（S） | 20,000 | US$45.00 | US$900,000.00 | 105,211 | SEC |
| 2026-05-04 2026-05-06 | TVTX Travere Therapeutics, Inc. | Meckler Jeffrey A Director | 卖出（S） | 8,000 | US$45.00 | US$360,000.00 | 87,500 | SEC |
| 2026-05-04 2026-05-06 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 20,000 | US$45.00 | US$900,000.00 | 111,473 | SEC |
| 2026-05-01 2026-05-04 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. Director | 卖出（S） | 9,750 | US$44.22 | US$431,145.00 | 37,500 | SEC |
| 2026-04-22 2026-04-23 | TVTX Travere Therapeutics, Inc. | ROTE WILLIAM E. Officer · Chief Research Officer | 卖出（S） | 9,100 | US$39.09 | US$355,719.00 | 113,987 | SEC |
| 2026-04-15 2026-04-15 | TVTX Travere Therapeutics, Inc. | REED ELIZABETH E Officer · Chief Legal Officer and GC | 卖出（S） | 1,559 | US$42.53 | US$66,304.27 | 105,211 | SEC |
| 2026-04-15 2026-04-15 | TVTX Travere Therapeutics, Inc. | REED ELIZABETH E Officer · Chief Legal Officer and GC | 卖出（S） | 5,226 | US$41.62 | US$217,506.12 | 106,770 | SEC |
| 2026-04-15 2026-04-15 | TVTX Travere Therapeutics, Inc. | Dube Eric M Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 56,815 | US$41.01 | US$233万 | 440,071 | SEC |
| 2026-04-15 2026-04-15 | TVTX Travere Therapeutics, Inc. | Dube Eric M Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 20 | US$42.66 | US$853.20 | 432,886 | SEC |
| 2026-04-15 2026-04-15 | TVTX Travere Therapeutics, Inc. | Dube Eric M Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 7,165 | US$41.75 | US$299,138.75 | 432,906 | SEC |
| 2026-04-15 2026-04-15 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 1,018 | US$42.61 | US$43,376.98 | 111,473 | SEC |
| 2026-04-15 2026-04-15 | TVTX Travere Therapeutics, Inc. | Cline Christopher R. Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 1,014 | US$42.61 | US$43,206.54 | 116,899 | SEC |
| 2026-04-14 2026-04-16 | TVTX Travere Therapeutics, Inc. | LYONS GARY A Director | 卖出（S） | 8,000 | US$41.07 | US$328,560.00 | 57,500 | SEC |
| 2026-04-14 2026-04-16 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. Director | 卖出（S） | 26,000 | US$41.07 | US$106.78万 | 44,250 | SEC |
| 2026-04-14 2026-04-16 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. Director | 卖出（S） | 6,750 | US$42.12 | US$284,310.00 | 37,500 | SEC |
| 2026-04-14 2026-04-16 | TVTX Travere Therapeutics, Inc. | Calvin Sandra Officer · SVP, CHIEF ACCOUNTING OFFICER | 卖出（S） | 21,977 | US$41.07 | US$902,595.39 | 42,353 | SEC |
| 2026-04-14 2026-04-15 | TVTX Travere Therapeutics, Inc. | REED ELIZABETH E Officer · Chief Legal Officer and GC | 卖出（S） | 37,500 | US$41.07 | US$154.01万 | 119,211 | SEC |
| 2026-04-14 2026-04-15 | TVTX Travere Therapeutics, Inc. | REED ELIZABETH E Officer · Chief Legal Officer and GC | 卖出（S） | 7,215 | US$41.93 | US$302,524.95 | 111,996 | SEC |
| 2026-04-14 2026-04-15 | TVTX Travere Therapeutics, Inc. | Heerma Peter Officer · CHIEF COMMERCIAL OFFICER | 卖出（S） | 7,215 | US$41.93 | US$302,524.95 | 138,608 | SEC |
| 2026-04-14 2026-04-15 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 7,215 | US$41.93 | US$302,524.95 | 112,491 | SEC |
| 2026-04-14 2026-04-15 | TVTX Travere Therapeutics, Inc. | Cline Christopher R. Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 7,239 | US$41.93 | US$303,531.27 | 117,913 | SEC |
| 2026-04-14 2026-04-15 | TVTX Travere Therapeutics, Inc. | Cline Christopher R. Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 9 | US$41.07 | US$369.63 | 125,152 | SEC |
| 2026-04-13 2026-04-15 | TVTX Travere Therapeutics, Inc. | Cline Christopher R. Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 65 | US$28.85 | US$1,875.25 | 125,161 | SEC |
| 2026-04-06 2026-04-07 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. Director | 卖出（S） | 10,000 | US$33.00 | US$330,000.00 | 37,500 | SEC |
| 2026-04-01 2026-04-02 | TVTX Travere Therapeutics, Inc. | REED ELIZABETH E Officer · Chief Legal Officer and GC | 卖出（S） | 10,000 | US$30.00 | US$300,000.00 | 105,211 | SEC |
| 2026-04-01 2026-04-02 | TVTX Travere Therapeutics, Inc. | Dube Eric M Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 25,098 | US$31.46 | US$789,583.08 | 432,886 | SEC |
| 2026-04-01 2026-04-02 | TVTX Travere Therapeutics, Inc. | Dube Eric M Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 34,902 | US$30.55 | US$106.63万 | 457,984 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| TVTX | 434,969.8904 | 0 | 746,306.8063 | 58.28% | B, Q, N |